Immunoglobulin G (Novo Nordisk)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameImmunoglobulin G (Novo Nordisk)
Drug Alias NameImmunoglobulin intravenous (Novo Nordisk)Nordimmun
ClassificationBiologics > Blood componentsBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsImmunologic Deficiency Syndromes
Global Approved IndicationsImmunologic Deficiency Syndromes
Approved Indications in ChinaN/A
Original Approved Country/TerritoryDenmark
Original Approved Date1991/01/01
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk A/S
Inactive CompaniesN/A
Active IndicationsImmunologic Deficiency Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeJ06BA02
Related LinksWikipediaDrugBankKEGG